Hydrocortisone cream is a corticosteroid for use in dermatology.
Conditions that respond to topical corticosteroids (eczema, dermatitis, psoriasis). Topical corticosteroids are generally not indicated for the treatment of psoriasis but may be acceptable, except in widespread plaque psoriasis, with precautions.
Warehouse
1 g of the drug contains 1 mg of hydrocortisone butyrate; excipients: cetostearyl alcohol, polyethylene glycol cetostearyl ether, mineral oil, white soft paraffin, methylparaben (E 218), propylparaben (E 216), citric acid, sodium citrate, purified water.
Contraindication
Except in cases of treatment in combination with appropriate chemotherapeutic agents:
Skin lesions (wounds) caused by bacterial infections (e.g. pyoderma, syphilitic or tuberculous lesions), viral infections (e.g. chickenpox, herpes simplex, herpes zoster, common warts, flat warts); infections caused by fungi and yeasts; parasitic infections (e.g. scabies); ulcerative skin lesions; adverse reactions caused by corticosteroids (e.g. perioral dermatitis, striae); ichthyosis, juvenile plantar dermatosis, acne vulgaris, rosacea, fragility of skin vessels, skin atrophy; allergic reactions of hypersensitivity to the components of the drug or corticosteroids (the latter occur rarely); skin neoplasms.
Method of application
For cutaneous use.
Apply the drug in a small amount in a thin, even layer to the affected areas no more than 2 times a day.
It can be applied under an occlusive dressing in the presence of more persistent lesions, such as thickened psoriatic plaques on the elbows and knees (excluding weeping lesions).
Dosage
The total course dose should not exceed 30–60 g of cream per week.
Application features
Topical corticosteroids can be dangerous for patients with psoriasis for a number of reasons, including rebound syndrome due to tolerance, the risk of generalized pustular psoriasis, or local and systemic toxicities due to impaired skin barrier function. Steroids may be used in scalp psoriasis or in chronic plaque psoriasis of the hands and feet. Close monitoring is important.
Pregnant women
There are no or limited amount of data from the use of hydrocortisone butyrate in pregnant women.
Children
Can be used for children from 6 months.
Drivers
There is no data on the effect of the drug “Hydrocortisone Cream” on the ability to drive or operate other mechanisms; no effect is expected.
Overdose
Excessive use under occlusive dressing may cause adrenal suppression. There is no specific treatment or antidote. If any adverse effects occur, treatment should be discontinued and symptomatic treatment should be administered.
Side effects
Skin and subcutaneous tissue disorders: dermatitis, eczema, striae, contact dermatitis, contact allergy, pustular acne, skin atrophy, often irreversible, accompanied by thinning of the epidermis, telangiectasias, purpura and striae.
Storage conditions
Store in the original packaging at a temperature not exceeding 25°C.
Do not refrigerate. Keep out of reach of children.
